Clean Science & Technology Earnings Call Transcript: Key Takeaways
Record consolidated quarter, with HALS revenue doubling YoY. Standalone margins compressed as raw-material inflation could not be passed on to customers.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
48 announcements
Record consolidated quarter, with HALS revenue doubling YoY. Standalone margins compressed as raw-material inflation could not be passed on to customers.
Q2 FY27 consolidated revenue ₹299 Cr (+22% YoY), PAT ₹56 Cr (+0.5%), EBITDA margin 31.2% (vs 36.4%). HALS-led growth; margins hit by geopolitical headwinds.
Clean Science & Technology Ltd reported revenue from operations of ₹299.4 Cr (+22.4% YoY) and net profit of ₹55.7 Cr (+0.5% YoY) for Q2 FY27.
Clean Science's subsidiary Clean Fino-Chem completed product trials for advanced HALS grades developed with Geneus Chem AG. Commercial launch of the new range is expected in H2 FY2026-27.
Clean Science and Technology Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Clean Science and Technology Ltd has scheduled a board meeting for October 31, 2026, to approve unaudited financial results for the quarter and half year ending September 2026.
Clean Science concluded GST proceedings, resulting in a ₹2.0 crore net financial impact. A further ₹9.9 crore liability is recoverable as Input Tax Credit.
CRISIL reaffirmed Clean Science's long-term rating at AA-/Stable and short-term at A1+. The rating action signals continued stable credit quality with no change.
GST authorities initiated search and seizure proceedings at the company's premises. The company reports no material impact on financials or business operations at this stage.
Clean Science and Technology invested Rs. 50.00 Crore to subscribe to additional equity shares of its wholly-owned subsidiary, Clean Fino-Chem Limited, for project funding.
Clean Science and Technology Limited has appointed Mr. Krishnakumar Satyanarain Saboo as an Executive Director, effective August 1, 2026, for a five-year term.
Clean Science and Technology Limited held its 23rd AGM on September 12, 2026. Shareholders approved all agenda items, including the final dividend declaration.
Clean Science and Technology Limited has allotted 1,601 equity shares to eligible employees under its Employee Stock Option Scheme 2021.
Clean Science and Technology's subsidiary, Clean Fino-Chem, incorporated a new subsidiary in the Netherlands, Clean Science International B.V., with initial capital of EUR 50,000.
Clean Science and Technology Limited will hold its 23rd AGM on September 12, 2026. The company has released its FY2025-26 Annual Report and notice for dividend declaration.
Clean Science and Technology Limited submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details environmental, social, and governance disclosures as mandated by SEBI.
Clean Science and Technology Limited has released its Annual Report for FY 2025-26. The 23rd Annual General Meeting is scheduled for September 12, 2026.
Clean Science reports record consolidated sales driven by the HALS segment scaling up, though legacy business faced raw material supply disruptions. Management is aggressively pivoting toward high-margin, advanced HALS chemistry via a new Swiss strategic collaboration.
Clean Science and Technology appointed Mr. Krishnakumar Satyanarain Saboo as Additional Director and proposed Whole-time Director, effective August 1, 2026.
Clean Science and Technology Limited confirmed the AGM date for September 12, 2026, and Book Closure period for the previously approved dividend for FY 2025-26.
Clean Science and Technology announced its Annual General Meeting date, book closure period, and dividend payment schedule following the previously approved final dividend for FY26.
Clean Science reported its highest-ever consolidated sales for Q1 FY27, reaching INR 268 Cr, driven by the HALS series expansion despite global headwinds.
Clean Science & Technology Ltd reported revenue from operations of ₹268.4 Cr (+10.5% YoY) and net profit of ₹73.3 Cr (+4.6% YoY) for Q1 FY27.
Clean Science and Technology signed a long-term, five-year supply arrangement with Kemin Industries to provide key ingredients for the food and feed sector.
Clean Science's subsidiary, Clean-Fino Chem, will incorporate a wholly-owned subsidiary in the Netherlands. The initial capital investment is approximately ₹0.55 Crore.
Clean Science and Technology disclosed inter-se promoter transfers involving the gifting of shares to various family trusts and individuals during the quarter.
Clean Science and Technology will hold a board meeting on August 1, 2026. The board will consider Q1 FY27 un-audited financial results.
Clean Science's subsidiary entered a strategic collaboration with Geneus Chem AG. The deal includes a long-term supply agreement and acquisition of a 25% stake.
Promoter group members transferred 2,00,38,000 shares via off-market gifts. Total promoter holding remained unchanged after the inter-se transaction.
Clean Science and Technology invested ₹50 Crore in its wholly-owned subsidiary, Clean Fino-Chem Limited. The capital will fund the subsidiary's various projects.